RSV Hospitalizations in Comparison With Regional RSV Activity and Inpatient Palivizumab Administration, 2010-2013

Alexander F Glick1,2, Stephanie Kjelleren3, Annika M Hofstetter4,5,6

  • 1New York-Presbyterian Hospital, New York, New York; alexander.glick@nyumc.org.

Hospital Pediatrics
|April 7, 2017
PubMed

Insights

Pediatric respiratory syncytial virus (RSV) hospitalizations often precede regional activity. High-risk infants may need earlier RSV immunoprophylaxis due to varied hospitalization patterns.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of pediatric hospitalization.
  • Understanding the timing of RSV hospitalizations relative to regional activity is crucial for resource allocation and prevention strategies.
  • Palivizumab is a monoclonal antibody used for RSV immunoprophylaxis in high-risk infants.

Purpose of the Study:

  • To compare the timing of pediatric respiratory syncytial virus (RSV) hospitalizations in the United States with regional RSV activity.
  • To analyze the timing of inpatient palivizumab administration in relation to RSV seasons.

Main Methods:

  • Characterized RSV hospitalizations from the Pediatric Health Information System (July 2010-June 2013).
  • Defined RSV hospitalization and activity seasons based on surveillance data.
  • Used logistic regression to identify predictors of hospitalization timing and assessed palivizumab administration timing.

Main Results:

  • Mean RSV hospitalization season onset (early November) preceded regional activity season onset (early December) by 3.3 weeks.
  • Nearly 10% of RSV hospitalizations occurred outside the defined regional activity season.
  • Children with chronic conditions were more likely to be hospitalized after the regional activity season, while African American children were hospitalized earlier.

Conclusions:

  • Significant regional variations exist in RSV hospitalization and activity patterns.
  • A substantial proportion of RSV hospitalizations occur before the peak of regional RSV activity.
  • Findings suggest that high-risk infants may benefit from earlier initiation of RSV immunoprophylaxis.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...